XOMA Royalty (XOMA) Equity Income (2024 - 2026)

XOMA Royalty's (XOMA) quarterly Equity Income came in at $100000.0 in Q1 2026, up 108.72% year-on-year from $47911.4 in Q1 2025, and up 170.27% quarter-over-quarter from $37000.0 in Q4 2025.

XOMA Royalty (XOMA) Equity Income (2024 - 2026) Analysis & Trends

XOMA Royalty has disclosed Equity Income across 3 years of filings, most recently posting $100000.0 for Q1 2026.

  • Equity Income for Q1 2026 came in at $100000.0, up 108.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 293.46% YoY), and the FY2025 annual result was $3.7 million, up 3600.0% from the prior year.
  • Equity Income came in at $100000.0 for Q1 2026 at XOMA Royalty, up from $37000.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $6.3 million in Q2 2025 to a low of -$3.9 million in Q3 2025.
  • The 3-year median for Equity Income is $63000.0 (2024), against an average of $151750.0.
  • Peak annual rise in Equity Income reached 2133.22% in 2025, while the deepest fall reached 4531.46% in 2025.
  • XOMA Royalty's Equity Income stood at -$524000.0 in 2024, then surged by 107.06% to $37000.0 in 2025, then surged by 170.27% to $100000.0 in 2026.
  • The last three Equity Income figures came in at $100000.0 (Q1 2026), $37000.0 (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 235,807.00
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - 100,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Dec 31, 2025 37,000.00
Sep 30, 2025 -3.94 Mn
Jun 30, 2025 6.32 Mn
Mar 31, 2025 -1.15 Mn
Dec 31, 2024 -524,000.00
Sep 30, 2024 89,000.00
Jun 30, 2024 283,000.00